| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443557 | European Journal of Cancer | 2014 | 8 Pages |
Abstract
Neither primary tumour volume, nor total nodal volume is a prognostic factor for patients with cT2-4 laryngeal cancer treated with accelerated radiotherapy ± carbogen breathing and nicotinamide. Additional analyses based on individual nodal volumes demonstrate an excellent regional control rate and a significant benefit of ARCON.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Geert O. Janssens, Liselotte W. van Bockel, Patricia A. Doornaert, Hendrik P. Bijl, Piet van den Ende, Martin A. de Jong, Guido B. van den Broek, Berit M. Verbist, Chris H. Terhaard, Paul N. Span, Johannes H. Kaanders,